πŸ‡ͺπŸ‡¬ Country Profile

Egypt

Expanding pharmaceutical supply to Egypt

πŸ‡ͺπŸ‡¬ $202M
All data from DGCIS India export records (fiscal year, April–March).
$202M
Scale
Egypt's healthcare system receives $202M in Indian pharmaceutical products each year β€” affordable, quality medicine.
67%
Medicine
Primarily medicine ingredients (67%), supplemented by medicines and vaccines.
2.2Γ—
Trajectory
India's pharmaceutical supply to Egypt has grown 2.2Γ— over the past decade β€” strong, sustained expansion.
Context
Part of India's pharmaceutical supply network across Africa.
✦
Impact
Indian pharmaceutical companies have both exported to and invested directly in Egypt β€” building trade and operational presence.
Export Trend DGCIS FY
Pharmaceutical Composition Trend DGCIS CY 2014–2025

All pharma categories from DGCIS (487-code basket)

Category Mix — FY 2025–26 DGCIS
Medicine Ingredients $135M (67.1%) Medicines $32.8M (16.2%) Vaccines $24.1M (11.9%) Surgical & Hospital Supplies $8.1M (4.0%) Traditional & Herbal $1.4M (0.7%)
Top Products — FY 2025–26 DGCIS
Indian Pharma Investment in Egypt Source: RBI ODI Data

Total RBI-approved ODI commitments by Indian pharmaceutical companies into Egypt: $8.3M across 25 filings (2011-2022).